(Q39445443)

12 September 2017

title

Cyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene delivery (English)

1 reference

12 September 2017

Changyou Zhan

1

1 reference

12 September 2017

Qinggang Meng

2

1 reference

12 September 2017

Qinghua Li

3

1 reference

12 September 2017

Linglin Feng

4

1 reference

12 September 2017

Jianhua Zhu

5

1 reference

12 September 2017

Weiyue Lu

6

1 reference

12 September 2017

publication date

9 November 2011

1 reference

Chemistry - An Asian Journal

12 September 2017

published in

1 reference

12 September 2017

volume

7

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

91-96

1 reference

Angiogenesis in brain tumours

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Host microvasculature influence on tumor vascular morphology and endothelial gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Microvascular abnormalities in virally-induced canine brain tumors. Structural bases for altered blood-brain barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Basement membrane invasion of glioma cells mediated by integrin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Ligands for mapping alphavbeta3-integrin expression in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Gene expression, biodistribution, and pharmacoscintigraphic evaluation of chondroitin sulfate-PEI nanoconstructs mediated tumor gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Targeting of the beta(2)-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Poly(ethylene glycol)-grafted polyethylenimine modified with G250 monoclonal antibody for tumor gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Cyclic RGD-poly(ethylene glycol)-polyethyleneimine is more suitable for glioblastoma targeting gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Gene therapy strategies for tumor antiangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Structure and function of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Chemotherapy delivery issues in central nervous system malignancy: a reality check.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201100570

21 January 2018

Identifiers

DOI

10.1002/ASIA.201100570

1 reference

12 September 2017

1 reference